Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

Last updated: December 17, 2024
Sponsor: Stanford University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Lymphoma

Hodgkin's Disease

Treatment

N/A

Clinical Study ID

NCT00398177
LYM0001
LYM0001
76973
IRB-13500
  • Ages > 18
  • All Genders

Study Summary

The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellularclassification, any stage, any grade.

  • Adult or pediatric patients receiving lymph node excision for purposes other thancancer therapy (i.e. tonsillectomy, sleep apnea).

  • A routine procedure for tissue collection is planned.

  • Ability to understand and the willingness to sign a written informed consent.

Exclusion

Exclusion Criteria:

  • Patients without NHL or Hodgkin's disease

Study Design

Total Participants: 9999
Study Start date:
January 01, 1999
Estimated Completion Date:
January 31, 2099

Study Description

This research involves the study of lymphoma cells in order to better understand how the disease grows and spreads. This study may lead to the development of special materials that could be used, in the future, to treat lymphoma or to follow the response of lymphoma to treatment.

Connect with a study center

  • Stanford University School of Medicine

    Stanford, California 94305
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.